Antisense oligonucleotide based therapeutics and its applications against bacterial infections
The transcriptome of a cell governs the overall cellular expression of proteins, hence, targeting mRNA holds promise as a therapeutic strategy in the field of drug discovery. RNA therapeutics especially, antisense oligonucleotide (ASO) technology, have gained tremendous pace in the last few decades...
Saved in:
Main Authors: | Nupur Angrish (Author), Garima Khare (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antisense Oligonucleotide-Based Therapy of Viral Infections
by: Woan-Yuh Tarn, et al.
Published: (2021) -
Antisense Oligonucleotides: Concepts and Pharmaceutical Applications
by: Ariana Araya, et al.
Published: (2023) -
Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
by: Davide Di Fusco, et al.
Published: (2019) -
Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics
by: Bao T. Le, et al.
Published: (2019) -
Making Sense of Antisense Oligonucleotide Therapeutics Targeting Bcl-2
by: Maria Gagliardi, et al.
Published: (2022)